Status:
COMPLETED
STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic
Lead Sponsor:
Université du Québec à Trois-Rivières
Collaborating Sponsors:
Public Health Agency of Canada (PHAC)
Canada Research Chairs Endowment of the Federal Government of Canada
Conditions:
Psychological
Mental Health Issue
Eligibility:
FEMALE
18-50 years
Phase:
PHASE1
Brief Summary
STEP-COVID (Supporting the Transition to and Engagement in Parenthood during the COVID-19 pandemic) is a manualized group intervention for pregnant women during the COVID-19 pandemic designed to foste...
Detailed Description
The program aims to (a) support mentalization in relation to oneself, motherhood and the relationship with the child to be born, (b) reduce isolation by allowing participants to exchange about the pos...
Eligibility Criteria
Inclusion
- Pregnant women ages 18+ years
- Interested in reflecting about their experience of pregnancy and willing to attend weekly sessions in group setting.
- Must speak French as their first language
Exclusion
- Severe psychiatric disorders (schizophrenia, bipolar disorder)
- Severe emotional dysregulation
- Current self-harm
- Not sure to keep the child
- High level of hostility
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05419167
Start Date
September 1 2020
End Date
December 10 2022
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada, G9A5H7